Skip to main content
logo
Akebia Therapeutics, Inc. (FRA:AX9)
Germany flag Germany · Delayed Price · Currency is EUR
1.350
+0.004 (0.30%)
At close: Dec 1, 2025

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202014 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2014 - 2019
Novel Therapeutics
160.18M
Log In
Log In
Log In
Log In
Upgrade
Novel Therapeutics Growth
-17.70%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202014 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2014 - 2019
United States
160.18M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-17.70%
Log In
Log In
Log In
Log In
Upgrade